OncoCyte Co. (NASDAQ:OCX) Sees Large Decrease in Short Inter
OncoCyte Co. (NASDAQ:OCX) Sees Large Decrease in Short Interest
OncoCyte Co. (NASDAQ:OCX – Free Report) was the recipient of a large decline in short interest in June. As of June 15th, there was short interest totalling 1,070,000 shares, a decline of 24.6% from the May 31st total of 1,420,000 shares. Based on an average daily volume of 335,500 shares, the short-interest ratio is presently […]
Related Keywords
United States, , Vanguard Group Inc, Oncocyte Company Profile, Goldman Sachs Group Inc, Oncocyte Corporation, Oncocyte Co, Millennium Management, Defender Capital, Nasdaq, Pura Vida Investments Llc, Needham Company, Balyasny Asset Management, Securities Exchange Commission, Free Report, Pura Vida Investments, Exchange Commission, Sachs Group, Asset Management, Cyte Corporation, Oncocyte Daily,